Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo

Retrovirology. 2010 Mar 11:7:17. doi: 10.1186/1742-4690-7-17.

Abstract

Background: Adult T cell leukemia results from the malignant transformation of a CD4+ lymphoid clone carrying an integrated HTLV-1 provirus that has undergone several oncogenic events over a 30-60 year period of persistent clonal expansion. Both CD4+ and CD8+ lymphocytes are infected in vivo; their expansion relies on CD4+ cell cycling and on the prevention of CD8+ cell death. Cloned infected CD4+ but not CD8+ T cells from patients without malignancy also add up nuclear and mitotic defects typical of genetic instability related to the expression of the virus-encoded oncogene tax. HTLV-1 expression is cancer-prone in vitro, but in vivo numerous selection forces act to maintain T cell homeostasis and are possibly involved in clonal selection.

Results: Here we demonstrate that the HTLV-1 associated CD4+ preleukemic phenotype and the specific patterns of CD4+ and CD8+ clonal expansion are in vivo selected processes. By comparing the effects of recent (1 month) experimental infections performed in vitro and those observed in cloned T cells from patients infected for >6-26 years, we found that in chronically HTLV-1 infected individuals, HTLV-1 positive clones are selected for tax expression. In vivo, infected CD4+ cells are positively selected for cell cycling whereas infected CD8+ cells and uninfected CD4+ cells are negatively selected for the same processes. In contrast, the known HTLV-1-dependent prevention of CD8+ T cell death pertains to both in vivo and in vitro infected cells.

Conclusions: Therefore, virus-cell interactions alone are not sufficient to initiate early leukemogenesis in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes / virology*
  • CD8-Positive T-Lymphocytes / virology*
  • Cell Death*
  • Cell Proliferation*
  • Cell Transformation, Viral
  • Gene Expression
  • Genes, pX*
  • Host-Pathogen Interactions
  • Human T-lymphotropic virus 1 / pathogenicity*
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell / virology*